3D-QSAR Design of New Escitalopram Derivatives for the Treatment of Major Depressive Disorders
Abstract
Share and Cite
AVRAM, S.; BUIU, C.; DUDA-SEIMAN, D.M.; DUDA-SEIMAN, C.; MIHAILESCU, D. 3D-QSAR Design of New Escitalopram Derivatives for the Treatment of Major Depressive Disorders. Sci. Pharm. 2010, 78, 233-248. https://doi.org/10.3797/scipharm.0912-22
AVRAM S, BUIU C, DUDA-SEIMAN DM, DUDA-SEIMAN C, MIHAILESCU D. 3D-QSAR Design of New Escitalopram Derivatives for the Treatment of Major Depressive Disorders. Scientia Pharmaceutica. 2010; 78(2):233-248. https://doi.org/10.3797/scipharm.0912-22
Chicago/Turabian StyleAVRAM, Speranta, Catalin BUIU, Daniel M. DUDA-SEIMAN, Corina DUDA-SEIMAN, and Dan MIHAILESCU. 2010. "3D-QSAR Design of New Escitalopram Derivatives for the Treatment of Major Depressive Disorders" Scientia Pharmaceutica 78, no. 2: 233-248. https://doi.org/10.3797/scipharm.0912-22
APA StyleAVRAM, S., BUIU, C., DUDA-SEIMAN, D. M., DUDA-SEIMAN, C., & MIHAILESCU, D. (2010). 3D-QSAR Design of New Escitalopram Derivatives for the Treatment of Major Depressive Disorders. Scientia Pharmaceutica, 78(2), 233-248. https://doi.org/10.3797/scipharm.0912-22